25 of the Best Neurologists Near Me in hanover, MD

Mohammad Khoshnoodi is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Khoshnoodi is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Peripheral Neuropathy, Guillain-Barre Syndrome, Chronic Polyradiculoneuritis, and Miller-Fisher Syndrome. Dr. Khoshnoodi is board certified in American Board Of Psychiatry And Neurology. Dr. Khoshnoodi is currently accepting new patients.

Liana Rosenthal, M.D. is an Assistant Professor in the Department of Neurology at Johns Hopkins University School of Medicine in Baltimore, Maryland. Dr. Rosenthal completed medical school at Johns Hopkins with an internship at Johns Hopkins Bayview Medical Center. She completed her neurology residency and movement disorder fellowship at The Johns Hopkins Hospital. Dr. Rosenthal is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Movement Disorders, Parkinson's Disease, Olivopontocerebellar Atrophy, and Spinocerebellar Ataxia. Dr. Rosenthal is board certified in American Board Of Psychiatry And Neurology. Dr. Rosenthal is currently accepting new patients.

Brenda Banwell is the director of the Department of Pediatrics, as well as pediatrician-in-chief and co-director of Johns Hopkins Children’s Center, where she helps manage the hospital’s many clinical and research centers. Dr. Banwell is a renowned expert in the research and treatment of pediatric multiple sclerosis (MS) and other neuroimmune disorders. She specializes in and studies the use of neuroimaging to assess the clinical and cognitive impact of the conditions, as well as the function of the immune system in children with these disorders. She also created a standardized clinical care algorithm and clinical database in order to evaluate the clinical impact of MS. Dr. Banwell has published more than 250 manuscripts in high-impact journals, along with over 25 book chapters. In addition, she has over 200 national and international invited lectureships and visiting professorships. An advocate for pediatric multiple sclerosis needs and research, Dr. Banwell serves as chair of the International Medical and Scientific Board of the Multiple Sclerosis International Federation, and the Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease (MOGAD) International Research Consortium. She is also chair of the pediatric committee of the National Institutes of Health NeuroNEXT program, which conducts studies on treatments for neurological diseases through academic, private, and industry collaborations. Dr. Banwell currently serves as past-chair of the International Pediatric Multiple Sclerosis Study Group, Dr. Banwell earned her medical degree from the University of Western Ontario. She later completed a residency in pediatrics at the University of Western Ontario-Children's Hospital of Western Ontario and a second residency in pediatric neurology at University of Toronto – The Hospital for Sick Children. Her residencies were followed by a fellowship in neuromuscular research at Mayo Clinic. Dr. Banwell is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Multiple Sclerosis (MS), CACH Syndrome, Optic Neuritis, and Transverse Myelitis. Dr. Banwell is board certified in Royal College Of Physicians And Surgeons Of Canada. Dr. Banwell is currently accepting new patients.

Dr. Ahmet Hoke is Professor of Neurology and Neuroscience, W. W. Smith Charitable Trust Professor of Neuroimmunology at Johns Hopkins School of Medicine, Director of the Daniel B. Drachman Division of Neuromuscular Diseases and Director of the Merkin Peripheral Neuropathy and Nerve Regeneration Center at Johns Hopkins University School of Medicine. He completed his medical training at Hacettepe University School of Medicine in Ankara, Turkey followed by his PhD studies in developmental neuroscience at Case Western Reserve University in Cleveland, Ohio, and neurology residency at Johns Hopkins Hospital. After completing his neuromuscular training at University of Calgary, Canada, he returned to Johns Hopkins University as faculty and rose through the ranks. He is the recipient of several awards including Derek Denny Brown Young Neurological Scholar Award (2005) and Wolfe Neuropathy Research prize (2018) given by the American Neurological Association, Myung Memorial Lecture Award (2017) by the Korean Neurological Association, Nejat Eczacibasi Medical Scientist Award (2019) by the Eczacibasi Foundation, Turkey, and Alan J. Gebhart Prize in Excellence in Neuropathy Research (2022) by the Peripheral Nerve Society. He is an Ex-Officio member of the Board of Directors of the American Neurological Association, and Vice-President of the Toxic Neuropathy Consortium. He serves on several editorial boards and is the Editor-in-Chief of Annals of Clinical and Translational Neurology. Dr. Hoke is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Wallerian Degeneration, Peripheral Neuropathy, Tomaculous Neuropathy, Spinal Muscular Atrophy with Arthrogryposis, and Prostatectomy. Dr. Hoke is board certified in American Board Of Psychiatry And Neurology. Dr. Hoke is currently accepting new patients.

Carlos Romo, M.D., is a neuro-oncologist in Baltimore, Maryland. Dr. Romo specializes in the diagnosis and treatment of brain tumors, including glioblastoma, astrocytomas, oligodendrogliomas, neurofibromas, and schwannomas among others. Dr. Romo earned his medical degree from the School of Medicine and Health Sciences at Tecnológico de Monterrey in Mexico and completed his Neurology residency at the University of Arkansas for Medical Sciences, where he served as chief resident. He then completed a Neuro-oncology clinical and research fellowship in a joint program between The Johns Hopkins University and the National Institutes of Health. Dr. Romo additionally trained as a clinical pharmacology fellow at The Johns Hopkins University and completed training on clinical cancer research at the University of Texas MD Anderson Cancer Center. In his research, Dr. Romo studies drug pharmacokinetics and the blood-brain barrier, and investigates better ways to reach tumors in the central nervous system. Dr. Romo also studies treatments for patient with neurofibromatosis. In addition to patient care and research, Dr. Romo teaches and mentors medical and undergraduate students to help develop a future generation of neurologists. Dr. Romo is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Neurofibromatosis, Neurofibromatosis Type 1 (NF1), Schwannomatosis, and Neurofibromatosis Type 2 (NF2). Dr. Romo is board certified in American Board Of Psychiatry And Neurology. Dr. Romo is currently accepting new patients.

With fellowship training in neuro-ophthalmology and additional training in neuro-vestibular disorders, Dr. Daniel Gold sees patients with neuro-ophthalmic disorders (affecting vision, eyelids, pupils, or causing nystagmus or double vision) in addition to oto-neurologic disorders (causing dizziness and vertigo). Videos 2018 Best Consulting Physician Award Tele-(Dizzy) Medicine. Dr. Gold is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Vertigo, Benign Paroxysmal Positional Vertigo, Brown Syndrome, and Stiff Person Syndrome. Dr. Gold is board certified in American Board Of Psychiatry And Neurology. Dr. Gold is currently accepting new patients.

Dr. Gregory Krauss focuses on the evaluation and treatment of seizures and epilepsy. He has a particular interest in treating medically-resistant epilepsy, evaluating unexplained seizure-like episodes, treating seizures associated with tumor and systemic illnesses and family planning counseling for patients with epilepsy. Dr. Krauss also evaluates patients who have failed standard medical therapies for possible treatment with epilepsy surgery, investigational medications or vagal nerve stimulation. Dr. Gregory Krauss received his medical degree from Oregon Health Sciences University. He then completed an internship in medicine at Greenwich Hospital. He went on to complete both a residency in neurology and a fellowship in epilepsy and electrophysiology at The Johns Hopkins Hospital. Dr. Krauss currently sees patients at The Johns Hopkins Outpatient Center in Baltimore on Tuesdays and Wednesdays. Dr. Krauss is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Seizures, Generalized Tonic-Clonic Seizure, Epilepsy, and Photosensitive Epilepsy. Dr. Krauss is board certified in American Board Of Psychiatry And Neurology. Dr. Krauss is currently accepting new patients.

Dr. Nathan Crone focuses on the diagnosis and treatment of seizures and epilepsy, including the surgical treatment of epilepsy. He is also one of the attending physicians in the Epilepsy monitoring unit. Dr. Crone''s research interests include the real-time mapping of brain function to reduce the possibility of impacting brain function during surgery for epilepsy. He received his medical degree from Louisiana State University School of Medicine. He then completed his residency in neurology at the University of Chicago and fellowships in epilepsy and cognitive neurology at Johns Hopkins. Dr. Crone is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Seizures, Epilepsy, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Autosomal Dominant Partial Epilepsy with Auditory Features, and Deep Brain Stimulation. Dr. Crone is board certified in American Board Of Psychiatry And Neurology. Dr. Crone is currently accepting new patients.

Dr. Mowry became interested in multiple sclerosis (MS) prior to beginning college and first performed MS research as an undergraduate biology major at Georgetown University. As a neurology resident at the University of Pennsylvania, she began her multiple sclerosis clinical research activities in conducting a study of visual dysfunction and quality of life in multiple sclerosis. During her fellowship at UCSF, Dr. Mowry evaluated prognostic factors in multiple sclerosis and examined health-related quality of life in multiple sclerosis, particularly as a marker of disease burden. She also earned a Master’s Degree in Clinical Research at UCSF. Dr. Mowry continued as a member of the faculty there before joining the Johns Hopkins Department of Neurology as an Assistant Professor in July, 2011; she received a joint appointment in Epidemiology in 2013. She was appointed as the inaugural Richard T. and Frances W. Johnson Professor in 2022. Over the past several years, Dr. Mowry has worked primarily to perform epidemiologic investigations of multiple sclerosis (MS) risk and prognostic factors and has evaluated both genetic and environmental contributors. While she has had a major role in several such studies, her most significant work led to the identification of the association of vitamin D status with relapse and brain lesion risk in patients with MS (Annals of Neurology 2010, Annals of Neurology 2012, European Journal of Neurology 2015). She also conducted the first pilot study comparing gut bacterial populations in patients with MS and healthy individuals (Journal of Investigative Medicine 2014). She was recently funded to investigate the impact of vitamin D supplementation on the metabolomics profile in patients with MS compared to healthy controls. She enjoys designing and conducting clinical trials in MS and is the Principal Investigator of the Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) multicenter vitamin D trial (NCT01490502), which is sponsored by the National MS Society and a smaller multicenter pilot study investigating vitamin D pharmacokinetics in MS patients and healthy controls (NCT01667796). She is also the recipient of a Harry Weaver Award from the National MS Society, in which she is investigating the impact of intermittent calorie restriction in MS. Finally, as Director of the MS Experimental Therapeutics Program at Johns Hopkins, she assists colleagues with study design and helps oversee the conduct of MS clinical trials. Dr. Mowry is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Optic Neuritis, and Neuromyelitis Optica. Dr. Mowry is board certified in American Board Of Psychiatry And Neurology. Dr. Mowry is currently accepting new patients.

A leading expert on brain injury, Dr. Daniel F. Hanley has been a professor of neurology, neurosurgery, and anesthesiology/critical care medicine at the Johns Hopkins University School of Medicine since 1996 and was named the Jeffrey and Harriet Legum Chair of Acute Care Neurology. Dr. Hanley founded and directed the Johns Hopkins Neurocritical Care Unit, one of the first critical care units dedicated solely to neurosurgical and neurological patients. Subsequently, in 1999, he founded and continues to direct the BIOS Clinical Trials Coordinating Center (BIOS CTCC), formerly known as the Division of Brain Injury Outcomes. Under Dr. Hanley’s leadership, BIOS CTCC, an academic contract research organization based at Johns Hopkins, has organized and completed more than 20 large clinical trials. He has been awarded over 70 clinical and basic research grants, predominantly from the National Institutes of Health and the FDA Orphan Products Grants Program. Dr. Hanley’s 40-year career in medicine has focused on clinical trial design, the organization and interpretation of drug and device trials, the development of strategic research plans, and FDA regulatory compliance. He has led international, NIH-sponsored trials including the MISTIE III and CLEAR III trials investigating minimally invasive neurosurgical techniques to treat hemorrhagic stroke. As principal investigator for the National Center for Advancing Translational Sciences (NCATS) Johns Hopkins Trial Innovation Center, Dr. Hanley leads collaborative efforts to advance education and therapeutics through innovative CTSA clinical trials. Currently, Dr. Hanley is the PI or multi-PI for several ongoing trials. These include a multisite phase 2/3 randomized controlled dementia prevention trial (MAP), a large multicenter clinical trial involving automated monitoring of atrial fibrillation (REACT AF), and a first-in-patient phase 2a biomarker and edema attenuation in intracerebral hemorrhage trial (BEACH). Dr. Hanley has published over 400 peer-reviewed articles and book chapters, received the Humboldt Research Prize for accomplishments in brain injury research, and mentored nearly 100 researchers. His trainees, which include a large number of trialists, have led 25 brain intensive care units, and over 40 have been named full professors, program leaders, or department chairs. He has served on public boards including the American Academy of Neurology, National Stroke Association, and NIH National Institute of Nursing Research. Dr. Hanley is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Stroke, Hydrocephalus, Vertigo, Thrombectomy, and Gastrostomy. Dr. Hanley is board certified in American Board Of Psychiatry And Neurology and American Board Of Internal Medicine. Dr. Hanley is currently accepting new patients.

Dr. Stephen Grill is currently an Assistant Professor at Johns Hopkins University (JHU) in Baltimore and Chair of the Medical Advisory Board of the Parkinson Foundation of the National Capital Area (PFNCA). Dr. Grill received a Ph.D. in Neuroscience and an M.D. from Northwestern University. He then completed a neurology residency at Washington University and a fellowship in movement disorders at the National Institutes of Health. He was the founder of Parkinson’s & Movement Disorders Center of Maryland which is now Neurology Consultants – Parkinson’s & Movement Disorders Center of Maryland, a member of Johns Hopkins Regional Physicians. His research interests include how sensory information is used in the control of movement and how improper use of sensory information may lead to motor impairment. He treats persons with advanced Parkinson’s disease employing advanced technologies, such as Deep Brain Stimulation. Dr. Grill is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, and Restless Legs Syndrome. Dr. Grill is board certified in American Board Of Psychiatry And Neurology. Dr. Grill is currently accepting new patients.

Dr. Bhargava developed an interest in immunology early in medical school at the Christian Medical College in Vellore, India. He then completed his neurology training at the Southern Illinois University School of Medicine and while there began research in the field of multiple sclerosis (MS). Following his neurology training he completed a 3-year fellowship at the Johns Hopkins University in neuroimmunology and neurological infections focusing on MS clinical care and research. His fellowship training was supported by a Sylvia Lawry physician fellowship award from the National MS Society. His main research interests include studying the role of inflammation in the meninges in progression of MS disease. He is currently involved in a trial testing the utility of injecting a drug called rituximab into the spinal fluid in patients with progressive MS. He is also developing an animal model of the process of meningeal inflammation to test other potential treatments. This work is supported by awards from the National MS Society, Race to Erase MS and the American Academy of Neurology. He is also actively involved in studying the role of measuring lipids and small molecule metabolites in serum and plasma to help identify new biomarkers for improved diagnosis and prognosis of the disease. These methods could also help in better tracking the effects of various interventions and in personalizing the treatment of patients with MS. Dr. Bhargava is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), CACH Syndrome, and Transverse Myelitis. Dr. Bhargava is board certified in American Board Of Psychiatry And Neurology. Dr. Bhargava is currently accepting new patients.

Peter Calabresi is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Calabresi is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Multiple Sclerosis (MS), Optic Neuritis, Relapsing Multiple Sclerosis (RMS), and CACH Syndrome. Dr. Calabresi is currently accepting new patients.

Jennifer Hopp is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Hopp is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Seizures, Memory Loss, Epilepsy, and Generalized Tonic-Clonic Seizure. Dr. Hopp is board certified in American Board Of Psychiatry And Neurology - Clinical Neurophysiology, 2007, American Board Of Psychiatry And Neurology - Epilepsy, 2016, and American Board Of Psychiatry And Neurology - Neurology, 2004. Dr. Hopp is currently accepting new patients.

Bassel Shneker is a Neurologist and a Psychiatrist practicing medicine in Columbia, Maryland. Dr. Shneker is highly rated in 49 conditions, according to our data. His clinical expertise encompasses Cervical Myelopathy, Hemangioblastoma, Dysembryoplastic Neuroepithelial Tumors (DNET), and Brain Stem Cancer. Dr. Shneker is board certified in Clinical Neurophysiology, American Board Of Psychiatry And Neurology , Epilepsy, American Board Of Psychiatry And Neurology , American Board Of Psychiatry And Neurology Neurology, American Board Of Internal Medicine - Psychiatry & Neurology, Neurology - 2027, and American Board Of Internal Medicine - Neurology - 2027. Dr. Shneker is currently accepting new patients.

Vijay Maggio is a Neurologist practicing medicine in Columbia, Maryland. Dr. Maggio is highly rated in 39 conditions, according to our data. Her clinical expertise encompasses Cervical Myelopathy, Spinal Tumor, Subependymoma, and Brain Stem Cancer. Dr. Maggio is board certified in American Board Of Psychiatry And Neurology, Clinical Neurophysiology , American Board Of Clinical Neurophysiology, American Board Of Psychiatry And Neurology , American Board Of Psychiatry & Neurology - Neurology - 2027, American Board Of Psychiatry And Neurology, Neurology, and American Board Of Psychiatry & Neurology - Clinical Neurophysiology - 2027. Dr. Maggio is currently accepting new patients.

Richard Choi is a Neurologist practicing medicine in Glen Burnie, Maryland. He has been practicing medicine for over 18 years. Dr. Choi is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Stroke, Apoplexy, Subarachnoid Hemorrhage, Transmyocardial Revascularization, and Stent Placement. Dr. Choi is currently accepting new patients.

Carl Ansevin is a Neurologist practicing medicine in Columbia, Maryland. Dr. Ansevin is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Cervical Myelopathy, Dysembryoplastic Neuroepithelial Tumors (DNET), Brain Stem Cancer, and Posterior Fossa Tumor. Dr. Ansevin is board certified in American Board Of Psychiatry And Neurology, Clinical Neurophysiology , American Board Of Psychiatry And Neurology Neurology, Clinical Neurophysiology, American Board Of Psychiatry And Neurology , American Board Of Psychiatry & Neurology - Neurology - 2027, American Board Of Psychiatry And Neurology, Neurology, and American Board Of Psychiatry & Neurology - Clinical Neurophysiology - 2027. Dr. Ansevin is currently accepting new patients.

Dr. Moukheiber trained in neurology at Tufts Medical Center and completed his fellowship in movement disorders at Johns Hopkins. His primary interests include using telehealth/teleneurology to help bridge the gap between tertiary care available in well-funded facilities and the dearth of it in significantly underserved and remote areas; especially pertaining to movement disorders in general and ataxia in particular. He has worked with a number of non-government organizations and founded his own entity that provides home health care in the form of advanced nursing, physical therapy and occupational therapy to underserved communities in third world countries, with particular emphasis on neurodegenerative diseases. Dr. Moukheiber is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Stiff Person Syndrome, Movement Disorders, Parkinson's Disease, and Drug Induced Dyskinesia. Dr. Moukheiber is board certified in American Board Of Psychiatry And Neurology. Dr. Moukheiber is currently accepting new patients.

Dr. Leung obtained her undergraduate degree in biochemical sciences from Harvard University. While attending medical school at Duke University, she completed a year-long research fellowship studying genetic markers of late-onset Alzheimer’s disease at the National Institute on Aging as part of the NIH Clinical Research Training Program. She completed her neurology residency and clinical neurophysiology fellowship at Stanford University Medical Center, and is currently a Ph.D. candidate in the graduate training program in clinical investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Leung joined the Center for Genetic Muscle Disorders at the Kennedy Krieger Institute as a translational research fellow in 2010 and was appointed to the faculty in 2014. Her clinic specializes in electromyography and the diagnosis and treatment of hereditary muscle diseases. Dr. Leung’s research focuses on the development of imaging biomarkers and outcome measures for muscle diseases. She is the principal investigator for a longitudinal cohort study of whole-body MRI in facioscapulohumeral muscular dystrophy. Dr. Leung is also a site principal investigator for the Ionis-DMPKRx trial, a phase Ib/IIa clinical trial of a novel RNA-based therapy for myotonic muscular dystrophy. Dr. Leung is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Facioscapulohumeral Muscular Dystrophy (FSHD), Limb-Girdle Muscular Dystrophy Type 2I, Limb-Girdle Muscular Dystrophy, and Dysferlinopathy. Dr. Leung is board certified in American Board Of Psychiatry And Neurology. Dr. Leung is currently accepting new patients.

Dr. Barañano earned her M.D. and Ph.D. degrees from the Johns Hopkins University School of Medicine, where she also completed residencies in pediatrics and neurology, along with a fellowship in neurogenetics at the Kennedy Krieger Institute. Dr. Barañano is an Associate Professor of Clinical Neurology. She specializes in the diagnosis and management of rare neurogenetic disorders. She has a particular interest in the genetic control and function of the cerebellum and expertise in childhood-onset and inherited ataxias. She is a member of the multidisciplinary Fetal Management group and is available for prenatal consultations. Dr. Barañano's research includes collaborative efforts with the Johns Hopkins Department of Genetic Medicine and the Division of Neurogenetics at the Kennedy Krieger Institute. Dr. Baranano is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Hypotonia, Ohdo Syndrome, Say-Barber-Biesecker-Young-Simpson Variant, Focal or Multifocal Malformations in Neuronal Migration, and Spinocerebellar Ataxia Type 3. Dr. Baranano is board certified in American Board Of Psychiatry And Neurology. Dr. Baranano is currently accepting new patients.

Dr. Michael Polydefkis focuses on neuromuscular diseases, particularly peripheral nerve diseases. He has a special interest in diabetic and HIV-associated peripheral neuropathy. His expertise includes nerve conduction studies, electromyography and nerve, skin and muscle biopsy reading. Dr. Michael Polydefkis received his medical degree from The Johns Hopkins University School of Medicine. He then became a Howard Hughes Medical Institute research fellow before returning to Johns Hopkins to complete an internship and residency in internal medicine, residency in neurology and a fellowship in neuromuscular diseases. Dr. Polydefkis is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Transthyretin Amyloidosis, Familial Transthyretin Amyloidosis, Primary Amyloidosis, and Peripheral Neuropathy. Dr. Polydefkis is currently accepting new patients.

Karisa Schreck is co-director of the BRAF Brain Tumor Center at Johns Hopkins. Her research focuses on the development of small-molecule targeted therapies for patients with primary brain tumors. Dr. Schreck has specific expertise in the treatment of BRAF gene mutations. As such, she works with Christine Pratilas’ laboratory to investigate resistance mechanisms to BRAF-targeted therapy. Dr. Schreck also writes and runs clinical trials for novel targeted agents through the Comprehensive Brain Tumor Center and the Alliance for Clinical Trials in Oncology. Dr. Schreck is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Glioma, Brain Tumor, Astrocytoma, and Glioblastoma. Dr. Schreck is board certified in American Board Of Psychiatry And Neurology. Dr. Schreck is currently accepting new patients.

Frederick Nahm is a Neurologist and a Neuroradiologist practicing medicine in Columbia, Maryland. Dr. Nahm is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Cervical Myelopathy, Dysembryoplastic Neuroepithelial Tumors (DNET), Brain Stem Cancer, and Invertebral Disc Disease. Dr. Nahm is board certified in American Board Of Psychiatry & Neurology, Neurology , American Board Of Psychiatry And Neurology Neurology , American Board Of Electrodiagnostic Medicine , American Board Of Psychiatry And Neurology, Neurology, and American Board Of Electrodiagnostic Medicine. Dr. Nahm is currently accepting new patients.

Avindra Nath is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Nath is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Encephalitis, Progressive Multifocal Leukoencephalopathy, CACH Syndrome, and Stroke.